The World Muscle Society Annual International Congress is the foremost event in the field of neuromuscular disorders.
Each year, more than 1,000 delegates from around the world come together to share the latest science in the field, network, share ideas and enhance the global knowledge of many of these life-limiting diseases.
“I found the Congress to be a very valuable opportunity to make new connections. I also really enjoyed hearing from the industry representatives in the industry symposia. The third session of oral presentations about RNA in NMD was by far the most interesting to me”.
Our work with sponsors and exhibitors is essential to the success of the annual Congress. The support of industry partners enables us to harness the power of the latest technology and provide opportunities to attend for those who might otherwise miss out.
Our 2026 Congress will take place in Hiroshima, Japan from 29 September to 3 October, with the Pre-Congress Teaching Course running through 28 and 29 September. It has been 16 years since we have hosted a WMS Congress in Asia and we are looking forward to welcoming delegates from across the continent and around the world.
If you aim to engage with new partners, foster collaboration, enhance your organisation's visibility, and elevate its standing, then the 31st Congress of the WMS presents an exceptional opportunity. This event will draw neuromuscular stakeholders from across the globe, fostering both physical and online interactions, and creating a platform for sharing, collaboration, learning, and inspiration.
Our sponsors and exhibitors benefit from:
To support sponsors and exhibitors of all sizes, we have created a series of sponsorship opportunities that align with our sponsors' organisational goals. Opportunities include hosting one of the sought-after Industry Symposia, sponsoring our networking reception or Congress transport, and taking a stand in our exhibition space.
Use the button below to register and receive the WMS 2026 Congress prospectus, now available.
WMS 2026 has been listed as compliant by Ethical MedTech, reference EMT-26-08858
Any sponsor showcasing pharmaceutical (or pharma-dependent) products is advised to consult the IPCAA (International Pharmaceutical Congress Advisory Association), EFPIA Code of Practice (European Federation of Pharmaceuticals Industries & Associations), IFPMA (International Federation of Pharmaceutical Manufacturers & Associations), and the MedTech Europe Code of Ethical Business Practice before applying.
For sponsors located in the USA or Canada, the sponsor must comply for the avoidance of doubt with such applicable laws, regulations, and codes of practice, including, without limitation, those promulgated by the FDA (U.S. Food & Drugs Administration), and Advamed, to the extent applicable.
It is the exhibitor or sponsor’s responsibility to comply with all national and international laws and regulations that pertain to its particular industry and to ensure that a compliance officer has approved the specific sponsorship items before the application.
Advertising and promotional activities at WMS 2026 (including symposia sessions, digital promotion opportunities, and exhibitions) must be limited to pharmaceuticals and medical devices authorised for marketing in Japan, and all claims must remain strictly within the approved labelling and intended use (on-label); promotion of unapproved products and off-label use is not permitted.
Please see the JPMA code of conduct here.
All activities in Japan must comply with applicable Japanese laws and relevant Japanese industry codes; exhibitors and sponsors are responsible for their own internal compliance review. WMS 2026 is not liable for sponsors failing to comply with legal, ethical, and industry standards.
